Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Treatment algorithm for TNBC

Bora Lim • 9 Dec 2021
SABCS 2021
Breast Cancer Antibodies Sacituzumab govitecan

Bora Lim, MD, Baylor College of Medicine, Houston, TX, talks on triple-negative breast cancer (TNBC), touching on the development of treatment algorithms for patients. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Bora Lim

1:32
Highlights at SABCS 2021 for basic science and early-phase clinical trials
Bora Lim • 9 Dec 2021
1:48
Single-cell genomics and proteogenomics in cancer
Bora Lim • 9 Dec 2021
1:40
Advances in the management of inflammatory breast cancer
Bora Lim • 9 Dec 2021
1:43
How to tell when basic science discoveries are ready to translate?
Bora Lim • 9 Dec 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals